Loading...
XASX
NUC
Market cap8mUSD
Jul 06, Last price  
0.08AUD
1D
6.67%
1Q
-40.74%
IPO
-97.65%
Name

Nuchev Ltd

Chart & Performance

D1W1MN
XASX:NUC chart
P/E
P/S
0.55
EPS
Div Yield, %
Shrs. gr., 5y
27.10%
Rev. gr., 5y
5.25%
Revenues
23m
+102.21%
2,544,3573,441,2579,499,27817,763,25210,899,3429,723,8098,791,60111,344,71622,939,652
Net income
-4m
L-47.74%
-9,679,724-14,074,385-13,499,836-10,902,865-13,268,540-11,108,449-8,806,694-7,316,304-3,823,202
CFO
-4m
L+0.22%
-13,158,071-9,064,392-8,636,477-10,694,750-9,494,376-8,300,310-3,256,929-3,733,356-3,741,500

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nuchev Limited functions as a specialized health and nutrition company, responsible for the production, marketing, and distribution of infant formula and various nutritional items derived from goat milk. Its products are sold to consumers across Australia, China, and Vietnam. The firm offers a range of options under its Oli6 brand, including toddler nutrition, powdered goat milk, and general health and wellness goods. These products can be purchased through both conventional retail outlets and online e-commerce platforms. Nuchev Limited was established in 2013 and maintains its corporate headquarters in Melbourne, Australia.
IPO date
Dec 09, 2019
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT